Home›Stock Screener›Balaxi Pharmaceuticals›P/E Ratio

Balaxi Pharmaceuticals P/E Ratio

Current P/E Ratio
52.32
High Valuation
Very High - High growth expectations or significantly overvalued

Balaxi Pharmaceuticals P/E ratio. Balaxi Pharmaceuticals (BALAXI) P/E ratio is 52.32 (High), EPS (TTM) ₹0.26, current price ₹22.67 on NSE vs historical average P/E of 9.13 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Examine Balaxi Pharmaceuticals quarterly earnings for recent quarterly revenue, profit and EPS trends.

Current Valuation Metrics

P/E Ratio 52.32
Current Price ₹22.67
EPS (TTM) ₹0.26
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 9.13
Historical Range 0.5 - 42.11
Percentile 100.0%

Sector Context

Sector Average 56.21
Sector Median 32.41
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹1.95
Mar 2026 ₹0.11
Jun 2026 ₹0.24

BALAXI P/E Ratio — Valuation Signal & Historical Context

Balaxi Pharmaceuticals P/E 52.32 vs historical average 9.13, range 0.5–42.11 — signal: Overvalued. Also explore BALAXI share price charts to track price trends across different timeframes.

  • Stock appears overvalued with PE of 52.32, suggesting caution for new investments
  • Current PE is 473.2% above historical average

Balaxi Pharmaceuticals P/E Ratio Historical Trend

BALAXI annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 52.32 vs historical average 9.13. For live price, revenue and the complete fundamental profile, see BALAXI share price screener.

BALAXI Historical P/E Ratio — EPS, Year-End Price & Valuation

Balaxi Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.11 1.71 ₹72.00 NSE High
2024 6.5 13.39 ₹87.10 NSE Low
2022 2.05 50.56 ₹103.55 NSE Low
2021 2.96 43.3 ₹128.25 NSE Low
2020 0.5 31.23 ₹15.75 NSE Low
2019 0.65 9.26 ₹6.00 NSE Low

BALAXI vs Healthcare Peers — P/E Ratio Comparison

Balaxi Pharmaceuticals P/E 52.32 vs Healthcare average 56.21, median 32.41 — range 2.04–740.29.

Sector Average
56.21
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low